Drug makers chase anti-flu pill

Drug makers are targeting flu virus vulnerabilities to develop antivirals that not only stop infections in their tracks, but also temper emergence of drug resistance.
Cambridge, UK

Search for this author in:

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

doi: 10.1038/d41587-019-00013-8
Nature Briefing

Sign up for the daily Nature Briefing email newsletter

Stay up to date with what matters in science and why, handpicked from Nature and other publications worldwide.

Sign Up